Benzo[α]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line

Carcinogenesis

Volumn 19, Issue 7, 1998, Pages 1291-1297

  Tannheimer, Stacey L ^a   Ethier, Stephen P ^c   Caldwell, Kevin K ^b   Burchiel, Scott W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BENZO[A]PYRENE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; POLYCYCLIC AROMATIC HYDROCARBON; SOMATOMEDIN; CARCINOGEN; INSULIN; PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; TYROSINE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; BREAST EPITHELIUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BREAST; CELL DIVISION; CELL LINE; CELL SURVIVAL; CULTURE MEDIUM; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; BENZO(A)PYRENE; BREAST; CARCINOGENS; CELL DIVISION; CELL LINE; CELL SURVIVAL; CULTURE MEDIA; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; PHOSPHORYLATION; PROTEINS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TYROSINE;

EID: 0031595405     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.7.1291     Document Type: Article

References (48)

1. Pitot, H.C. and Dragan, Y.P. (1996) Chemical carcinogenesis. In Klassen, C.D. (ed.) Casarett and Doull's Toxicology. McGraw-Hill, New York, pp. 201-267.
2. Ethier, S.P. and Ullrich, R.L. (1982) Induction of mammary tumors in virgin female BALB/c mice by single low doses of 7,12-dimethylbenz[a]anthracene. J. Natl Cancer Inst., 69, 1199-1203.
3. Gould, M.N., Grau, D.R., Seidman, L.A. and Moore, C.J. (1986) Interspecies comparison of human and rat mammary epithelial cell-mediated mutagenesis by polycyclic aromatic hydrocarbons. Cancer Res., 46, 4942-4945.
4. Moore, C.J., Eldridge, S.R., Tricomi, W.A. and Gould, M.N. (1987) Quantitation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells. Cancer Res., 47, 2609-2613.
5. Eldridge, S.R., Gould, M.N. and Butterworth, B.E. (1992) Genotoxicity of environmental agents in human mammary epithelial cells. Cancer Res., 52, 5617-5621.
6. Miller, J.A. (1970) Carcinogenesis by chemicals: an overview. Clowes Memorial Lecture. Cancer Res., 30, 559-571.
7. Heidelberger, C. (1975) Chemical carcinogenesis. Annu. Rev. Biochem., 44, 79-121.
8. Dipple, A. (1994) Reactions of Polycyclic Aromatic Hydrocarbons with DNA. IARC Scientific Publication No. 125. IARC, Lyon, pp. 107-129.
9. 2+ in primary human mammary epithelial cells. Carcinogenesis, 18, 1177-1182.
10. 1, formation of inositol 1,4,5-triphosphate, and mobilization of intracellular calcium. Proc. Natl Acad. Sci. USA, 90, 6105-6109.
11. Krieger, J.A., Born, J.L. and Burchiel, S.W. (1994) Persistence of calcium elevation in the HPB-ALL T cell line correlates with immunosuppressive properties of polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol., 127, 268-274.
12. Mounho, B.J. and Burchiel, S.W. (1998) Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine kinase phosphorylation. Toxicol. Appl. Pharmacol., 149, 80-89.
13. Davila, D.R., Davis, D.P., Campbell, K., Cambier, J.C., Zigmond, L.A. and Burchiel, S.W. (1995) Role of alterations in calcium-associated signaling pathways in the immunotoxicity of polycyclic aromatic hydrocarbons. J. Toxicol. Environ. Health, 45, 101-126.
14. Enan, E. and Matsumura, F. (1995) Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachloro-p-dioxin (TCDD). Biochem. Pharmacol., 49, 249-261.
15. DeVito, M.J., Ma, X., Babish, J.G., Menache, M. and Birnbaum, L.S. (1994) Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol., 124, 82-90.
16. Ullrich, A. and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
17. Czech, M.P. (1989) Signal transmission by the insulin-like growth factors. Cell, 59, 235-238.
18. Ethier, S.P., Moorthy, R. and Dilts, C.A. (1991) Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells. Cell Growth Differentiat., 2, 593-602.
19. Ethier, S.P. and Moorthy, R. (1991) Multiple growth factor independence in rat mammary carcinoma cells. Breast Cancer Res. Treatment, 18, 73-81.
20. Ethier, S.P., Kudula, A. and Cundiff, K.C. (1987) Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro. J. Cell Physiol., 132, 161-167.
21. Vlahos, C.J., Matter, W.F., Hui, K.Y. and Brown, R.F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269, 5241-5248.
22. LeRoith, D., Sampson, P.C. and Roberts, C.T. (1994) How does the mitogenic insulin-like growth factor I receptor differ from the metabolic insulin receptor? Hormone Res., 41, 74-79.
23. Pronk, G.J., Vries-Smits, A.M.M., Buday, L., Downward, J., Maassen, J.A., Medema, R.H. and Bos, J.L. (1994) Involvement of she in insulin- and epidermal growth factor-induced activation of p21ras. Mol. Cell. Biol., 14, 1575-1581.
24. Myers, M.G., Sun, X.J. and Cheatham, B. (1993) IRS-1 is a common signaling element in insulin and insulin-like growth factor-I signaling to the phosphotidylinositol 3′-kinase. Endocrinology, 132, 1421-1430.
25. Skolnik, E.Y., Lee, C.H., Batzer, A.G., et al. (1993) The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and Shc: implications for insulin control of ras signalling. EMBO J., 12, 1929-1936.
26. Myers, M.G., Sun, X.J. and White, M.F. (1994) The IRS-1 signaling system. Trends Biochem. Sci., 19, 289-294.
27. Aaronson, S.A. (1991) Growth factors and cancer. Science, 254, 1146-1153.
28. Liu, H., Biegel, L., Narasimhan, T.R., Rowlands, C. and Safe, S. (1992) Inhibition of insulin-like growth factor-I responses in MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Mol. Cell. Endocrinol., 87, 19-28.
29. Gierthy, J.F., Bennett, J.A., Bradley, L.M. and Cutler, D.S. (1993) Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res., 53, 3149-3153.
30. Sasaoka, T., Draznin, B., Leitner, J.W., Langlois, W.J. and Olefsky, J.M. (1994) She is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J. Biol. Chem., 269, 10734-10738.
31. Owens, D.M. (1994) A mutant insulin receptor induces formation of a Shc-growth factor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS-1) with Grb2. Evidence for IRS-1-independent p21ras-GTP formation. J. Biol. Chem., 269, 33116-33122.
32. Varticovski, L., Harrison-Findik, D., Keeler, M.L. and Susa, M. (1994) Role of PI 3-kinase in mitogenesis. Biochim. Biophys. Acta, 1226, 1-11.
33. Toker, A. and Cantley, L.C. (1997) Signalling through the lipid products of phospho-inositide-3-OH kinase. Nature, 387, 673-676.
34. Myers, M.G., Backer, J.M., Sun, X.J., Shoelson, S.E., Hu, P. Schlessinger, J., Yoakim, M., Schaffhausen, B. and White, M.F. (1992) IRS-1 activates the phosphatidyinositol 3′-kinase by associating with the src homology 2 domains of p85. Proc. Natl Acad. Sci. USA, 89, 10350-10354.
35. Kennedy, S.G., Wagner, A.J., Conzen, S.D., Jordan, J., Bellacosa, A., Tsichlis, P.N. and Hay, N. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11, 701-713.
36. Whitman, M., Downes, C.P., Keeler, M., Keller, T. and Cantley, L. (1988) Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature (Lond.), 332, 644-646.
37. Osborne, C.K., Clemmons, D.R. and Arteaga, C.L. (1990) Regulation of breast cancer cell growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol., 37, 805-809.
38. Yee, D., Paik, S., Lebovic, G.S., Marcus, R.R., Favoni, R.E., Cullen, K.J., Lippman, M.E. and Rosen, N. (1989) Analysis of IGF-I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol., 3, 509-517.
39. Quinn, K.A., Treston, A.M., Unsworth, E.J., Miller, M.-J., Vos, M., Grimley, C. Battey, J., Mulshine, J.L. and Cuttitta, F. (1996) Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem., 271, 11477-11483.
40. Papa, V., Pezzino, V., Costatino, A., et al. (1990) Elevated insulin receptor content in human breast cancer. J. Clin. Invest., 86, 1503-1510.
41. Peyrat, J.P., Bonneterre, J., Vennin, P.H., Jammes, H., Beuscart, R., Hecquet, B., Djiane, J., Lefebvre, J. and Demaille, A. (1990) Insulin-like growth factor I receptors (IGF-IR) and IGF-I in human breast tumors. J. Steroid Biochem. Mol. Biol., 37, 823-827.
42. Poland, A. and Knutson, J.C. (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol., 22, 517-554.
43. Hoffer, A., Chang, C.-Y. and Puga, A. (1996) Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol. Appl. Pharmacol., 141, 238-247.
44. Leadon, S.A., Stampfer, M.R. and Bartley, J. (1988) Production of oxidative DNA damage during the metabolic activation of benzo[a]pyrene in human mammary epithelial cells correlates with cell killing. Proc. Natl Acad. Sci. USA, 85, 4365-4368.
45. Stohs, S.J., Shara, M.A., Alsharif, N.Z., Wahba, Z.Z. and Al-Bayati, Z.A.F. (1990) TCDD-induced oxidative stress in female rats. Toxicol. Appl. Pharmacol., 106, 126-135.
46. Tsiani, E., Abdullah, N. and Fantus, I.G. (1997) Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake. Am. J. Phys., 272, C156-C162.
47. Wei, H. and Frenkel, K. (1993) Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis, 14, 1195-1201.
48. Wolfle, D. and Marquardt, H. (1996) Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachloro-p-dioxin. Carcinogenesis, 17, 1273-1278.